BREAKTHROUGHS BLOG

July 29, 2012

Research Roundup: What we’re reading this week

Communications Officer
GHTC

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

A new bill introduced in the House of Representatives aims to tighten reporting requirements for ClinicalTrials.gov, the public online registry run by the National Institutes of Health.

The HIV/AIDS drug Truvada safely and effectively reduces the risk of HIV for certain at-risk populations, according to the first US Centers for Disease Control and Prevention guidelines on using the drugs for prevention.

Nature Medicine recently examined how several pharmaceutical companies are testing new drug candidates to treat drug-resistant tuberculosis.

The Government Accountability Office has released a new report that details regulatory policies and requirements put into place under various US global health programs.

The Bill & Melinda Gates Foundation announced that Dr. Orin Levine has been named director of Vaccine Delivery. Levine, a member of the GHTC, is currently a professor of International Health and executive director of the International Vaccine Access Center at the Johns Hopkins University’s Bloomberg School of Public Health.

back